About: Quantum dots as a promising agent to combat COVID‐19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Quantum dots as a promising agent to combat COVID‐19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Quantum dots as a promising agent to combat COVID‐19
Creator	Manivannan, Selvambigai Ponnuchamy, \|
Source	Medline; PMC
abstract	Approximately every 100 years, as witnessed in the last two centuries, we are facing an influenza pandemic, necessitating the need to combat a novel virus strain. As a result of the new coronavirus (severe acute respiratory syndrome coronavirus type 2 [SARS‐CoV‐2] outbreak in January 2020, many clinical studies are being carried out with the aim of combating or eradicating the disease altogether. However, so far, developing coronavirus disease 2019 (COVID‐19) detection kits or vaccines has remained elusive. In this regard, the development of antiviral nanomaterials by surface engineering with enhanced specificity might prove valuable to combat this novel virus. Quantum dots (QDs) are multifaceted agents with the ability to fight against/inhibit the activity of COVID‐19 virus. This article exclusively discusses the potential role of QDs as biosensors and antiviral agents for attenuation of viral infection.
has issue date	2020-06-26(xsd:dateTime)
bibo:doi	10.1002/aoc.5887
bibo:pmid	32836625
has license	no-cc
sha1sum (hex)	9a42173a2c04c01621c2ec8b530f58a4dbdb4822
schema:url	https://doi.org/10.1002/aoc.5887
resource representing a document's title	Quantum dots as a promising agent to combat COVID‐19
has PubMed Central identifier	PMC7361141
has PubMed identifier	32836625
schema:publication	Appl Organomet Chem
resource representing a document's body	covid:9a42173a2c04c01621c2ec8b530f58a4dbdb4822#body_text
is schema:about of	named entity 'therapeutic strategies' named entity 'functional group' named entity 'single-gene' named entity 'cell membranes' named entity 'hemagglutinin esterase' named entity 'antiviral agent' named entity 'COVID-19' named entity 'COVID' named entity 'spike protein' named entity 'lower respiratory tract' named entity 'glycyrrhizic acid' named entity 'molecular imaging' named entity 'nanomaterials' named entity 'viruses' named entity 'glucocorticoids' named entity 'lymph nodes' named entity 'genus' named entity 'COVID-19' named entity 'COVID-19' named entity 'combination of drugs' named entity 'Quantum dots' named entity 'SARS-CoV-2' named entity 'immunoglobulins' named entity 'remdesivir' named entity 'COVID-19' named entity 'Zika' named entity 'SARS-CoV-2' named entity 'molecular mechanism' named entity 'barley' named entity 'chloroquine' named entity 'hydroxychloroquine' named entity 'nucleic acid' named entity 'Quantum dots' named entity 'COVID-19' named entity 'social distancing' named entity 'quantum dot' named entity 'computed tomography scans' named entity 'hydrothermal carbonization' named entity 'COVID' named entity 'biocompatible' named entity '300 nm' named entity 'MERS-CoV' named entity 'SARS-CoV' named entity 'virus' named entity 'severe acute respiratory syndrome coronavirus' named entity 'host response' named entity 'porcine parvovirus' named entity 'vaccines' named entity 'protein' named entity 'protein' named entity 'broad spectrum' named entity 'COVID' named entity 'medical problems' named entity 'lungs' named entity 'COVID-19' named entity 'World Health Organization' named entity 'COVID' named entity 'benzoxazine' named entity 'viral entry' named entity 'ebolavirus' named entity 'nanomaterials' named entity 'stomach' named entity 'transcription' named entity 'ACE2' named entity 'antiviral therapy' named entity 'COVID' named entity 'enzyme' named entity 'viral replication' named entity 'clinical trials' named entity 'COVID-19' named entity 'alternative medical' named entity 'COVID-19.' named entity 'virus' named entity 'COVID-19' named entity 'severe acute respiratory syndrome coronavirus' named entity 'liver' named entity 'antibodies' named entity 'nanomaterials' named entity 'human coronavirus OC43' named entity 'pseudorabies virus'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software